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One of the core reactions in response to a stressful situation is the activation of the hypo-
thalamus–pituitary–adrenal axis which increases the release of glucocorticoid hormones
from the adrenal glands. In concert with other neuro-modulators, such as (nor)adrenaline,
these hormones enable and promote cognitive adaptation to stressful events. Recent stud-
ies have demonstrated that glucocorticoid hormones and noradrenaline, via their receptors,
can both rapidly and persistently regulate the function of excitatory synapses which are crit-
ical for storage of information. Here we will review how glucocorticoids and noradrenaline
alone and in synergy dynamically tune these synapses in the hippocampus and amygdala,
and discuss how these hormones interact to promote behavioral adaptation to stressful
situations.
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INTRODUCTION
Situationswhichpotentially disturbhomeostatic processes in body
and mind, and which are subjectively perceived as a threat, i.e.,
stress, initiate the activation of two systems aimed at helping the
organism to adapt (de Kloet et al., 2005; Kvetnansky et al., 2009;
McEwen and Gianaros, 2010). First, the autonomic nervous sys-
tem is activated upon arousal, ultimately causing the rapid release
of (nor)adrenaline from the adrenal medulla into the circulation
which– as ahormone– can rapidly regulate the functionof periph-
eral organs. Via indirect pathways involving the nucleus tractus
solitarius as well as more directly via activation of noradrener-
gic cells in the locus coeruleus, noradrenaline is also abundantly
released in the brain, including close to cells in limbic structures
like the amygdala and hippocampus (McGaugh, 2004; Valentino
and Von Bockstaele, 2008). In these areas, noradrenaline – as
a neurotransmitter – regulates neuronal function via α- and
β-adrenergic receptors (Gibbs and Summers, 2002; Roozendaal
et al., 2009a).
Somewhat later, the hypothalamus–pituitary–adrenal (HPA)
axis is activated, which causes the secretion of corticosteroid hor-
mones from the adrenal cortex. The prevailing corticosteroid
hormone inmost rodents is corticosterone, while in humans corti-
sol is most prevalent. Corticosteroid hormones are very lipophilic
and therefore easily pass the blood–brain barrier, in principle
reaching all cells but acting only on those carrying receptors.
Two types of corticosteroid receptors are expressed in the brain:
(1)mineralocorticoid receptors (MRs),which bind corticosterone,
cortisol, and aldosterone with high afﬁnity; and (2) glucocorticoid
receptors (GRs) with an approximately 10-fold lower afﬁnity for
corticosterone and cortisol (de Kloet et al., 2005). Due to this dif-
ference in afﬁnity, MRs are already substantially occupied by the
natural ligand under rest, whereas activation of GRs to a large
extent only occurs when corticosteroid levels are high, e.g., after
exposure to stressful experiences. Pyramidal cells in the hippocam-
pal CA1 area and granule cells in the dentate gyrus abundantly
express both MR and GR. In most other limbic areas, including in
the basolateral amygdala (BLA), expression of GR is higher than
that of MR; the exception is formed by CA3 pyramidal neurons,
which highly express MR but have only low levels of GR.
Corticosteroid hormones interact with various neurotransmit-
ter systems, e.g., serotonin, dopamine, and endocannabinoids (for
reviews, see Czyrak et al., 2003; Joëls et al., 2007; Hill et al., 2010;
Haj-Dahmane and Shen, 2011). In this review, the focus is on the
interactive effects of the neurotransmitter noradrenaline and the
hormone corticosterone, with respect to synaptic function and
behavioral relevance. While most cells in limbic brain regions are
exposed to both noradrenaline and corticosteroid hormones after
stressful events, the kinetic properties of exposure differ for the
two ligands (see Figure 1). In vivo microdialysis studies, e.g., in
the amygdala have shown that noradrenaline levels quickly rise
after stress, but are normalized within an hour (Quirarte et al.,
1998). By contrast, corticosteroid hormone levels in the brain are
raised with a delay of approximately 20 min (compared to the rise
observed in plasma; Droste et al., 2008) and return to baseline after
1–2 h. Catecholamines such as noradrenaline primarily act
through G-protein coupled receptors which, via second mes-
sengers, alter the functionality of ion channels. This causes
rapid-onset changes in electrical properties of neurons, which
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FIGURE 1 |Shortly after stress noradrenaline levels in the brain
are transiently elevated. Corticosteroids reach the same brain areas
later and remain elevated for approximately 2 h. For a restricted
period of time neurons are exposed to high levels of both hormones.
Noradrenaline primarily works through a rapid G-protein coupled pathway,
but long-lasting secondary genomic effects requiring gene transcription
may develop. Corticosteroid hormones exert rapid non-genomic actions
via membrane receptors, and also slowly, but persistently, regulate
neuronal function via nuclear receptors Corticosterone and noradrenaline
regulate synaptic transmission and promote memory performance, both
alone and in a synergistic fashion. For details, see text. Figure adapted
from Joëls et al. (2011).
generally are also quickly reversible when noradrenaline levels
in the synaptic cleft decline. Next to these rapid effects, gene-
mediated events may develop, e.g., via CREB, which may lastingly
affect synaptic function. This can induce a secondary, delayed
response to noradrenaline, starting by the time that rapid effects
have subsided, and last for hours.
In contrast to noradrenaline, corticosteroid hormones act
through receptors – i.e., MRs and GRs – known to be tran-
scriptional regulators (Duma et al., 2006). Upon binding of the
hormone to the intracellular receptor, the latter dissociates from
chaperone molecules and translocates to the nucleus, where it
binds to response elements in an estimated 1–2% of the genes
or, alternatively, changes gene transcription indirectly by inter-
fering with the efﬁcacy of other transcription factors. Both of
these pathways were indeed demonstrated to take place in the
brain (Morsink et al., 2006). Consequently, corticosteroid effects
on neuronal activity are generally slow in onset, developing with
a delay of approximately an hour, yet long-lasting. The most
prominent of these corticosteroid effects after stress are caused
by GR rather than MR activation (for review, see Joëls et al.,
2007). Over the past decade, though, it has become increas-
ingly evident that corticosteroid hormones also induce rapid
effects on neuronal activity, which involve non-genomic signal-
ing, via activation of MRs and GRs (Orchinik et al., 1991; Venero
and Borrell, 1999; Di et al., 2003; Karst et al., 2005, 2010; Groc
et al., 2008). Corticosteroid hormones can therefore rapidly and
persistently regulate neuronal function, via activation of MRs
and GRs.
Despite the different kinetics for adrenergic and steroid sig-
naling, there is a window in time during which cells in limbic
brain areas are simultaneously exposed to elevated levels of both
catecholamines and corticosteroid hormones, allowing these neu-
romodulators to affect neuronal processes in concert (Joëls et al.,
2011). Although, as mentioned, corticosteroid hormones are
known to interact with various neurotransmitter systems, we dis-
cuss in this review only how noradrenaline (as a neurotransmitter)
and corticosteroid hormones, alone or in interaction, regu-
late synaptic transmission (particularly via glutamate), synaptic
plasticity, and memory formation.
NORADRENALINE, CORTICOSTEROID HORMONES, AND
EXCITATORY SYNAPSES IN LIMBIC REGIONS
One important function of stress is to induce long-term adap-
tive responses. Enhanced memory for stressful events is one of
these well-knownhighly adaptive phenomena that help to remem-
ber relevant information. The current view of how memories
are formed is that neurons are activated during the learning
process, thereby changing the strength of synaptic connections
between these cells. These changes in synaptic strength are gener-
ally believed to underlie storage of information, and learning and
memory processes (Whitlock et al., 2006; Neves et al., 2008).
NORADRENERGIC EFFECTS ON AMPA RECEPTORS
There is ample evidence that the dynamic regulation of AMPA-
type glutamate receptors (AMPARs) – which mediate most
of the fast excitatory synaptic transmission in brain cells –
can change synaptic function and regulate storage of informa-
tion (Kessels and Malinow, 2009). Recent studies have revealed
that AMPARs are regulated by noradrenaline and glucocorti-
coid hormones. Thus, via activation of β-adrenergic receptors,
noradrenaline and stress can rapidly – but reversibly – acti-
vate PKA and CaMKII, and increase the phosphorylation of
GluA1 AMPAR subunits at Ser845 and Ser831 in the hippocam-
pus, a critical step for synaptic insertion of these receptors
(Wang et al., 2004; Hu et al., 2007). In addition, activation of
β-adrenergic receptors facilitates the induction of hippocampal
long-term potentiation (LTP; Thomas et al., 1996; Winder et al.,
1999; Hu et al., 2007; Tenorio et al., 2010) and enhances activity-
dependent synaptic insertion of AMPARs (Hu et al., 2007). Inter-
estingly, activation of β-adrenergic receptors facilitates LTP in
a time-dependent manner, i.e., only when receptors are phos-
phorylated by β-adrenergic activation, the induction of LTP is
enhanced.
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CORTICOSTEROID EFFECTS ON AMPA RECEPTORS IN THE
HIPPOCAMPUS AND PREFRONTAL CORTEX
Corticosteroid hormones can rapidly and reversibly change hip-
pocampal synaptic transmission. Rapid corticosteroid effects on
neuronal activity were ﬁrst described in detail for parvocellu-
lar neurons in the hypothalamic paraventricular nucleus (PVN;
reviewed in Tasker et al., 2006). In these cells, corticosterone
rapidly decreases the mEPSC frequency, via a retrograde sig-
naling pathway involving the endocannabinoid receptor 1. This
potentially suppresses activity of PVN cells. In neurons located
in the hippocampal CA1 area (Karst et al., 2005) and dentate
gyrus (Pasricha et al., 2011) however, mEPSC frequency is rapidly
and reversibly enhanced by corticosterone. Within minutes after
application, glucocorticoids increase synaptic transmission in the
hippocampus (Karst et al., 2005; Pasricha et al., 2011), via activa-
tion of low afﬁnity MRs which are probably located in the cellular
membrane. This rapid and reversible increase in synaptic trans-
mission after glucocorticoid exposure most likely results from
an increase in the presynaptic release of glutamate (Karst et al.,
2005) in which the Erk pathway is critically involved (Olijslagers
et al., 2008). Glucocorticoid exposure, via membrane MRs, also
rapidly increases lateral diffusion of GluA1 and GluA2 subunits
in primary hippocampal cultures, without altering the num-
ber of postsynaptic AMPARs (Groc et al., 2008) and promotes
the activity-dependent synaptic insertion of GluA2-containing
AMPARs (Groc et al., 2008). Furthermore, corticosterone shifts
the voltage-dependent activation of a transient K-conductance
(IA) to the right, thus reducing its inﬂuence during depolariza-
tion and thereby its inhibitory action (Olijslagers et al., 2008). All
of these actions potentially lead to a transiently raised hippocam-
pal activity shortly after stress. Finally, glucocorticoids facilitate
LTP in a time-dependent manner; LTP is only facilitated when
elevated corticosteroid levels are present at the moment of high-
frequency stimulation (Wiegert et al., 2006). These studies show
that both noradrenaline and glucocorticoids can rapidly facilitate
hippocampal synaptic plasticity and thereby increase the abil-
ity to encode information at the cellular level. The results are
not entirely unequivocal, though. Recently, dexamethasone–BSA
was reported to rapidly increase the frequency and amplitude
of hippocampal spontaneous GABAergic currents within min-
utes (Hu et al., 2010). GABAergic transmission is also enhanced
in the dorsal (but not ventral) hippocampus at a somewhat
slower timescale, starting 25 min after treatment onset (Maggio
and Segal, 2009). This would potentially decrease the activity of
hippocampal cells.
After exposure to a stressful event, plasma corticosteroid lev-
els slowly return to their pre-stress level, a process that requires
about 2 h (de Kloet et al., 2005). Still, these hormones exert – via a
slow, genomic mode of action – long-lasting effects on excitatory
synapses. In hippocampal primary cultures – which contain cells
from various hippocampal subregions – elevated glucocorticoid
levels increase the membrane expression and synaptic insertion
of GluA2-containing AMPARs (Groc et al., 2008; Martin et al.,
2009). These effects are mediated via GRs, require more than an
hour to develop as well as the synthesis of new proteins, and most
likely result from increased lateral diffusion and/or altered ratio
of endocytosis/exocytosis of GluA2-containing AMPARs (Groc
et al., 2008; Martin et al., 2009). In hippocampal primary neurons
as well as identiﬁed CA1 pyramidal cells, glucocorticoids slowly
increase the amplitude of evoked as well as spontaneous AMPAR-
mediated synaptic currents (Karst and Joëls, 2005; Martin et al.,
2009), thereby enhancing AMPAR-mediated synaptic transmis-
sion in speciﬁc synapses. A similar effect has been observed >1 h
after stress in prefrontal neurons, via the induction of serum-
and glucocorticoid-inducible kinase and the activation of Rab4
(Yuen et al., 2009, 2011). While LTP is enabled when plasma cor-
ticosterone levels are low, elevated plasma hormone levels slowly
suppress the ability to induce LTP (Diamond et al., 1992; Kim
and Diamond, 2002). Elevated plasma corticosterone levels may
hamper synaptic plasticity possibly because these hormones and
synaptic plasticity make use of overlapping signaling pathways,
which causes occlusion of one by the other (Groc et al., 2008).
Corticosteroids facilitate long-term depression (LTD; Coussens
et al., 1997; Xu et al., 1997) and increase endocytosis of synaptic
AMPARs upon stimuli that weaken synaptic transmission (Mar-
tin et al., 2009). A vast amount of studies has seen this pattern
of reduced LTP/enhanced LTD ﬁrst reported for the hippocam-
pus (see review in Kim and Diamond, 2002), but enhanced LTP
was reported for the ventral-most part (20%) of the hippocampus
(Maggio and Segal, 2007).
CORTICOSTEROID EFFECTS ON AMPA RECEPTORS IN THE
BASOLATERAL AMYGDALA
Activity of neurons in the BLA is mostly enhanced after corticos-
terone exposure in a slow GR-dependent way (Duvarci and Paré,
2007; Liebmann et al., 2008). BLA neurons respond rapidly to cor-
ticosterone in yet another manner. Thus, in slices prepared from
animals under rest, having very low circulating corticosterone
levels, exposure to corticosterone causes a non-genomic enhance-
ment in mEPSC frequency via MRs, similar to the hippocampus
(Karst et al., 2010). However, in BLA cells this enhancement is sus-
tained, a phenomenon that requires not only the presence of MR
but also of GR and protein synthesis. This alters the state of BLA
neurons such that they respond differently to renewed exposure
to corticosterone, now causing a decrease in mEPSC frequency,
via a rapid GR-dependent mechanism involving the endocannabi-
noid receptor 1, reminiscent of the mechanism described in
the PVN. BLA cells therefore seem – at least with respect to
the non-genomic corticosteroid actions – more sensitive to the
recent stress history of the animal than hippocampal CA1 and
dentate cells.
Taken together, these studies indicate that exposure of lim-
bic cells to either noradrenaline or corticosteroid hormones can
rapidly but also slowly regulate limbic glutamatergic synapses
(Krugers et al., 2010; Joëls et al., 2011).
AMPA RECEPTORS, STRESS, AND BEHAVIOR
Behavioral studies indicate that regulation of AMPARs by nora-
drenaline and corticosterone is relevant for learning and memory.
Studies using mice carrying mutations in the GluA1 phosphoryla-
tion sites indicate that noradrenaline-regulated phosphorylation
of GluA1 facilitates emotional memory in a contextual fear
conditioning task (Hu et al., 2007). Moreover, application of
pep2m, which blocks trafﬁcking of GluA2-containing AMPA
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receptors prevents the memory-enhancing effects of stress in
the Morris water-maze (Conboy and Sandi, 2010), and cued
fearful memories (Migues et al., 2010). Also, stress-induced
regulation of Rab4/SGK may underlie stress-effects on AMPA
receptor function in the prefrontal cortex and working memory
(Yuen et al., 2011).
CROSSTALK BETWEEN GLUCOCORTICOIDS AND
NORADRENALINE AT THE CELLULAR LEVEL
Noradrenaline and glucocorticoids not only change transmission
independent from each other but also interact to regulate excita-
tory synapses (Joëls et al., 2011). This interaction may take place
in two windows of time after exposure to a stressful experience.
In the ﬁrst window, shortly after exposure to stress, rapid non-
genomic actions of corticosteroids coincide with initial effects of
noradrenaline, so that interactions could take place while both
stress mediators are present in substantial amounts within 1 h
after stress and act on those cells carrying receptors for both types
of modulators. In the second window, presumably hours after
exposure to stress, corticosterone might also change noradren-
ergic actions via its slow genomic pathway, either when given
in advance of stress and/or noradrenaline (a pharmacological
approach) or in the aftermath of stress. In the following sections
we will discuss the current evidence for interactions, at the cel-
lular/circuit level, at the animal behavior level, and from human
research.
HIPPOCAMPUS
Recent data indicates that corticosterone and noradrenaline inter-
act to rapidly regulate AMPA receptor function at the cellular
level (Zhou et al., 2011). Thus, application of corticosterone for
15 min to hippocampal slices, at a dose that activates both MRs
and GRs (30 nM), did not affect phosphorylation of the AMPAR
GluA1 subunit at S845 or S831. Co-application of the β-adrenergic
receptor agonist isoproterenol, however, largely increased S845
(but not S831) phosphorylation. Similarly, corticosterone alone
did not rapidly change GluA1 and GluA2 surface expression in
hippocampal primary cultures. However, combined administra-
tion of corticosterone and isoproterenol – which by itself was
ineffective – enhanced surface expression. Interestingly, a high
dosage of isoproterenol in the absence of corticosterone enhanced
GluA1 surface expression, and this effect was decreased by cor-
ticosterone. Finally, in hippocampal primary cultures, mEPSC
frequency was enhanced by the combination of isoproterenol and
corticosterone (ineffective by themselves) while the same combi-
nation did not affect the amplitude. Although there are differences
in dose-dependency of these various interactive effects of corticos-
terone and noradrenaline – which might result from differences
in preparation –, the data indicates that there is an optimal com-
bination at which noradrenaline and corticosterone interact to
regulate AMPAR function and that beyond these concentrations
the combined responses decline.
These rapid interactions aimed at glutamatergic transmission
maybear relevance to observations at the circuit level in the dentate
gyrus (Pu et al., 2007). For instance, perforant path stimulation in
a theta-burst pattern – in slices from adult animals – by itself does
not induce synaptic potentiation, but application of isoproterenol
(1μM) just prior to and during high-frequency stimulation causes
robust synaptic potentiation. The onset of this potentiation is not
instantaneous and was found to be accelerated when corticos-
terone (100 nM) was applied in addition to isoproterenol. One
hour after high-frequency stimulation there was no difference
between the signals recorded from slices exposed to isoproterenol
alone or to the combination of the two hormones, suggesting that
there were no interactions in the later time-domain. However,
the 1-h delay may have been too short to reveal such interac-
tions. This explanation is supported by the fact that in slices
pretreated with a pulse of corticosterone >1 h before delivery
of isoproterenol (and high-frequency stimulation), a signiﬁcant
attenuation of the isoproterenol effect was observed. Given that
thus applied corticosterone by itself (i.e., without subsequent iso-
proterenol administration) did not change synaptic potentiation,
these data support interactive rather than additive actions of the
two hormones.
These observations in the dentate gyrus are in line with ﬁnd-
ings reported over two decades ago at the single cell level in
the CA1 area (Joëls and de Kloet, 1989). In CA1 pyramidal
neurons, noradrenaline (via β-adrenergic receptors) reduces a
calcium-dependent K-conductance, causing cells to ﬁre more
action potentials during a depolarizing episode. The efﬁcacy to do
so was strongly attenuated by pretreatment with corticosterone,
via a slow GR-dependent process. Thus, both in the hippocampal
CA1 area and dentate gyrus, β-adrenergic facilitation of excitabil-
ity is markedly attenuated by pretreatment with corticosterone via
a slow and presumably gene-mediated pathway.
BASOLATERAL AMYGDALA
In principal neurons of the BLA, isoproterenol causes a dose-
dependent rapid enhancement of AMPAR-mediated synaptic
responses, while the NMDAR mediated component is unaffected
(Liebmann et al., 2009). This was not altered by simultaneous
application of (100 nM) corticosterone. However, if corticos-
terone was applied >1 h in advance of isoproterenol, the
facilitation of AMPAR-mediated synaptic responses by a mod-
erate dose (0.4 μM) of the β-adrenoceptor agonist was strongly
reduced.
This interaction was mirrored in recordings at the circuit
level (Pu et al., 2009). Thus, isoproterenol was able to potenti-
ate synaptic (ﬁeld) responses for at least 60 min after delivery
of a mild tetanic stimulation. In contrast to what was seen in
the dentate gyrus, no acceleration of this effect by simultane-
ously applied corticosterone was observed. Instead, corticosterone
gradually reversed the effect of isoproterenol; the corticosteroid
hormone by itself did not affect synaptic responses after mild
tetanic stimulation. The gradually developing attenuation by cor-
ticosterone was even more pronounced when the hormone was
administered>1h in advance of isoproterenol andhigh-frequency
stimulation.
SOME PRINCIPLES ABOUT HORMONAL INTERACTIONS
AT THE SINGLE CELL/CIRCUIT LEVEL
Overall, these data at the single cell and circuit level shows that
at the short-term corticosterone may accelerate or enhance the
efﬁcacy of noradrenaline to facilitate synaptic transmission and
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potentiation in limbic cells (Joëls et al., 2011). These effects are
relatively mild, though, and not always apparent. There is evi-
dence that these interactions may only occur with intermediate
levels of synaptic input and/or moderately high hormone concen-
trations; when input/hormone levels are too low, interactive effects
remain sub-threshold, while too high levels of input/hormone lev-
els seem to cause ceiling or even reversed effects. An important
limitation of all studies so far is the fact that in actual life nora-
drenaline and corticosterone will not reach limbic cells at the exact
same moment. None of the studies so far has addressed this issue
(further discussed in Section “Conclusion”).
The slow genomic effect by corticosterone seems rather con-
sistent: attenuation of β-adrenergic actions by pretreatment with
corticosterone was observed in the hippocampal CA1 area and
dentate gyrus as well as the BLA. While an approach in which
corticosterone is given >1 h in advance of noradrenaline is phar-
macologically relevant and certainly has helped to delineate the
slow corticosteroid actions, there is paucity in studies examining
whether corticosterone co-administered with noradrenaline may
reverse and normalize noradrenergic actions after approximately
1 h. At this moment we can only infer such effects from the experi-
mental design using corticosteroid pretreatment. The exception is
formed by a study on synaptic potentiation in the BLA which pro-
vides preliminary evidence that corticosterone can indeed exert
such normalizing actions (Pu et al., 2009).
INTERACTIONS AT THE BEHAVIORAL LEVEL IN RODENTS
Noradrenaline and corticosteroid hormones, via their receptors,
mediate (at least in part) the memory-enhancing effects of stress
and emotion (Roozendaal et al., 2009a; Joëls et al., 2011). Nora-
drenaline enhances memory formation of emotional events via
brain β-adrenergic receptors: application of noradrenaline or
β-adrenergic receptor agonists promotes memory consolidation
in various aversive memory tasks such as inhibitory avoid-
ance task, fear conditioning and in Morris water-maze learning
(Hu et al., 2007; Roozendaal et al., 2009a; but see also Hatﬁeld
and McGaugh, 1999; Lee et al., 2001; Bush et al., 2010), and
blocking β-adrenergic receptors reduces contextual fear mem-
ories (Ji et al., 2003). Activation of α-adrenergic receptors also
enhances memory, presumably acting by enhancing β-adrenergic
actions (Ferry et al., 1999). Noradrenaline has also been reported
to enhance reconsolidation of information (e.g., Debiec and
LeDoux, 2004).
Corticosteroid hormones, via MRs have been implicated in
the appraisal and response selection during the learning process
(Oitzl and de Kloet, 1992; Sandi and Rose, 1994). Recent studies
provide evidence that MRs are involved in encoding of infor-
mation, possibly linked to effects on appraisal and/or response
selection. For instance, application of the MR antagonist spirono-
lactone prior to training lastingly suppressed the expression of
fear (Zhou et al., 2010). Moreover, genetic deletion of MRs in
the forebrain led to various cognitive impairments, including
impaired learning in a Morris water-maze task (Berger et al., 2006)
and reduced fear learning (Zhou et al., 2010). Via GRs, corti-
costeroid hormones have been reported to promote long-term
consolidation of information (de Kloet et al., 1999; Joëls et al.,
2006; Roozendaal et al., 2009a). For instance, a point mutation in
the mouse GR was found to impair spatial memory formation
(Oitzl et al., 2001), and blocking GRs impairs fear condition-
ing (Pugh et al., 1997a; Donley et al., 2005). In agreement, in
several fearful learning paradigms, such as fear conditioning
and inhibitory avoidance learning, post-training application of
corticosterone or GR agonists promotes the consolidation of
information (Corodimas et al., 1994; Sandi and Rose, 1994; Pugh
et al., 1997b; Hui et al., 2004). These studies imply that GRs
are involved in consolidation of (fearful) information and that
genomic actions are involved. This does not exclude the possi-
bility that other GR-dependent pathways are also involved. For
instance, a recent study suggested that membrane-associated GRs
too promote long-term memory in an object recognition task
via chromatin modiﬁcation (Roozendaal et al., 2010). Thus, it is
possible that both non-genomic as well as genomic actions of cor-
ticosteroid hormones, via GRs, promote the storage of relevant
information.
In addition to the well-documented effects of stress and gluco-
corticoids on consolidation processes, these hormones also affect
memory retrieval mechanisms (De Quervain et al., 1998). Expo-
sure to stress and elevated corticosteroid levels hamper the retrieval
of already stored information (De Quervain et al., 1998). Blocking
MRs and GRs also hampers the reconsolidation of context and
cue-conditioned fear respectively (Pitman et al., 2011; Zhou et al.,
2011). Taken together, there is ample evidence that corticosteroid
hormones, via activation of MRs and GRs, have a repertoire of
behavioral effects that promote the consolidation and updating
of relevant (fearful) information and ultimately favor behavioral
adaptation (de Kloet et al., 1999).
Several recent reviews (e.g., Roozendaal et al., 2009a) have
highlighted that particularly interactions between noradrenaline
and corticosterone affect (emotional) memory formation, a pro-
cess in which the hippocampus and amygdala play a crucial
role. We will here only describe a few examples which nicely
illustrate the principles. Thus, the presence of noradrenaline is
crucial for facilitation of emotional memory in rodents (Quirarte
et al., 1997). Moreover, post-training administration of nora-
drenaline or β-adrenergic receptor agonists into the BLA produces
a dose-dependent enhancement of amygdala-dependent mem-
ory formation (Ferry et al., 1999). Corticosterone can modulate
noradrenergic effects on memory formation but seems to be
unable to enhance memory formation independent of nora-
drenaline. This is most clearly demonstrated by an experiment
in which post-training corticosterone administration enhanced
spatial and aversive memory formation, a process blocked by
concurrent intra-BLA infusions of a β-adrenoceptor antagonist
(Roozendaal et al., 2006). Similarly, corticosterone administered
to naïve rats enhanced object recognition, an effect that was again
blocked by the β-adrenoceptor antagonist propranolol. Corticos-
terone was ineffective in rats with reduced training-associated
emotional arousal due to prior habituation to the experimen-
tal context (Okuda et al., 2004). Conversely, emotional arousal
effects were mimicked in well-habituated rats by releasing endoge-
nous noradrenaline via administration of the α2-adrenoceptor
antagonist yohimbine (presumably causing higher noradrenaline
levels) immediately after object recognition training (Roozendaal
et al., 2006).
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In contrast to the reduced preparations used for cellular stud-
ies, studies with intact animals should consider at least two other
aspects of interactions between the two hormones. First, corticos-
teroids are known to increase the availability of noradrenaline in
the BLA (McReynolds et al., 2010). Second, corticosteroid and
noradrenergic actions in one region cannot be regarded inde-
pendent from what happens in associated areas. For instance,
interactions between noradrenaline and corticosterone in the BLA
time-dependently inﬂuence the function of the dentate gyrus
(Akirav and Richter-Levin, 1999). Corticosteroids and nora-
drenaline also interact in the prefrontal or insular cortices to
enhance memory consolidation (Miranda et al., 2008; Roozen-
daal et al., 2009b). Thus, similar to what was described for
the BLA, administration of a β-adrenoceptor antagonist into
these brain regions prevents the memory enhancement by con-
currently administered corticosteroids (Barsegyan et al., 2010).
Due to reciprocal connections between the prefrontal cortex and
BLA, interactions in one area will almost certainly inﬂuence the
functionality in the other.
There is substantial evidence from behavioral studies that (of
the two types of corticosteroid receptors) at least GRs play a role
in the modulation of noradrenergic function (Roozendaal et al.,
2009a). The relatively short delay between hormone application
and behavioral effects seems to favor a non-genomic mode of
action. Rapid and presumably non-genomic effects via MRs, how-
ever, are also involved in successful memory formation under
arousing conditions (Zhou et al., 2010). To what extent genomic
actions of corticosteroids interact with noradrenaline to change
memory formation is more difﬁcult to assess. Nevertheless, there
is indirect evidence that such interactive effects do play a role. The
most straightforward example comes from a study using mice that
were geneticallymodiﬁed such thatGRs donot homodimerize and
thus cannot bind to the DNA (Oitzl et al., 2001). Training of these
animals in a water-maze paradigm – which is sufﬁciently stress-
ful to increase levels of both noradrenaline and corticosterone –
resulted in a poor spatial performance compared to the wildtype
controls. Calcium currents, and thus calcium-dependent attenu-
ation of ﬁring frequency, were not increased by corticosterone in
these mutant mice (Karst et al., 2000). This may allow for more
retrograde interference of stress-unrelated information, a possible
explanation for the impaired behavioral performance. Interest-
ingly, one behavioral study used a corticosterone-pretreatment
paradigm which quite closely resembles that used in cellular inves-
tigations. In this study (Borrell et al., 1984), pretreatment with
corticosteroids 1 h before adrenaline administration was demon-
strated to dramatically reduce the efﬁcacy of the latter to affect
amygdala-dependent behavior. Both examples support the view
that slow genomic GR effects reduce/normalize noradrenergic
actions on behavior, which is in line with the observations at the
cellular level.
INTERACTIONS IN THE HUMAN BRAIN
Most studies in humans indicate that stressful and emotional
events are remembered well. This most likely involves endogenous
catecholamines like noradrenaline (Cahill et al., 1994; Strange and
Dolan, 2004; Onur et al., 2009) but also corticosteroids (Lupien
et al., 2002; Marin et al., 2011). Several studies have speciﬁcally
investigated the interactions between noradrenaline and corti-
costeroid hormones. Some of these studies are discussed in the
following paragraphs.
Smeets et al. (2009) examined if stress exposure prior to encod-
ing of a list of words affected learning and memory performance.
The stressor consisted of public speaking about one’s personal-
ity in front of an unresponsive panel. The words to be learned
were either related to personality or unrelated to personality
but of comparable valence. Afterward each subject ranked all
words on an arousal-scale, allowing – on an individual basis –
a distinction between low-arousing and high-arousing words. It
turned out that stress improved learning and long-term memory
of high-arousing context-related words, at the cost of memoriz-
ing low-arousing context-related words, whereas no effect was
seen with regard to the context-unrelated words. The improved
memory for context-related high-arousing words was particularly
evident in individuals who performed the task immediately after
stress exposure, more so than in those who carried out the task 2 h
later. If the order was reversed (learning prior to stress exposure),
memory performance was unchanged. Interestingly, the memory
for high- versus low-arousing context-related words in subjects
stressed just prior to learning correlated signiﬁcantly with a com-
bined index for their salivary alpha-amylase and cortisol levels,
which reﬂect the function of the autonomic and HPA systems
respectively, but did not correlate with either of these parameters
alone, underlining the potential relevance of interactions between
the two systems.
Van Stegeren et al. (2010) used a pharmacological approach,
speciﬁcally addressing the interactive effect of the two hormones
on memory formation. Subjects received yohimbine and hydro-
cortisone, prior to encoding of arousing and neutral pictures. The
timing of hydrocortisone administration (45 min before encod-
ing) was slightly ambiguous, probably allowing the development
of non-genomic as well as genomic effects. At the behavioral
level, combined drug administration led to the best (surprise)
recognition of the pictures, particularly of arousing material.
Contrary to the observations in animals, hydrocortisone seemed
more effective than yohimbine in improving memory (see also
Maheu et al., 2005), but it cannot be excluded that the experi-
mental setting already caused substantial release of endogenous
catecholamines, so that exogenous administration of drugs tap-
ping on the same system were less effective. Paradoxically, the very
good memory performance in the group receiving both yohim-
bine and hydrocortisone was linked to reduced activity in the
hippocampus, as revealed by simultaneously acquired fMRI data.
Interestingly, this reduced hippocampal activity during encoding
of later remembered material was also observed when subjects
instead of receiving drugs were stressed during encoding (Henck-
ens et al., 2009). At this time one can only speculate about this
observation, but one explanation could be that under stressful
conditions extensive ﬁltering of the incoming information may
take place, causing restricted but highly efﬁcient functioning of
the human hippocampus.
A third example illustrating that noradrenaline and corticos-
teroids interact at the level of the amygdala in the human brain
was supplied by Kukolja et al. (2008). In this study subjects recei-
ved either (i) the noradrenaline-reuptake inhibitor reboxetine,
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(ii) hydrocortisone, (iii) a combination of these two drugs, or
(iv) placebo, 105 min before they entered the scanner. They were
exposed to ﬁlmclipswith actorswhodisplayed either a happy, fear-
ful or neutral facial expression. In control subjects happy or fearful
(compared toneutral) expressions cause enhanced amygdala activ-
ity. Subjects receiving both reboxetine and hydrocortisone showed
reduced amygdala activity to happy faces but enhanced activity
to fearful facial expressions. This suggests that noradrenaline in
interaction with cortisol gives rise to a negative bias of emotional
functions.
More recently this was conﬁrmed and extended in a study
which speciﬁcally targeted the delayed and presumably genomic
effects of cortisol administration under conditions that are proba-
bly sufﬁciently arousing to cause substantial release of endogenous
noradrenaline (Henckens et al., 2010). Subjects ingested a placebo
or a cortisol tablet (10 mg) either 75 or 285 min prior to exposure
to a face-morphing task of both happy and fearful facial expres-
sions while they were in a scanner. When given at 75 min prior to
the test, cortisol suppressed amygdala activity to both happy and
fearful faces.When cortisol was given 285min in advance, normal-
ized responses to fearful face stimuli but still reduced responses to
happy face stimuli were observed. As seen in the study by Kukolja
et al. (2008), this suggests a valence-speciﬁc slow corticosteroid
effect, causing diminished amygdala processing preferentially for
happy faces. Interestingly, normalization of the responses to
fearful face stimuli after 285 min correlated with increased mPFC-
amygdala connectivity, indicating augmented cognitive top-down
control (Henckens et al., 2010). This suggests an important inﬂu-
ence of delayed corticosteroid actions on executive functions, a
ﬁeld that is currently being explored.
Although the studies reported here represent only a selection of
papers on the effect of stress on human cognition, they nicely illus-
trate theprinciple that noradrenaline and corticosteroidhormones
interact to affect cognitive processing in the human brain.
OPEN QUESTIONS
When an organism experiences a stressful event, its neurons in
limbic brain structures are exposed to surges of bothnoradrenaline
and corticosteroids. In addition to these two important stress
mediators, there is a myriad of transmitters and hormones that
join in the overall central response to a stressful situation, includ-
ing catecholamines other than noradrenaline such as dopamine
and peptides like CRH and vasopressin (Joëls and Baram, 2009).
Here we discussed that corticosteroids and noradrenaline regu-
late the function of excitatory synapses and that this is thought
to contribute to the memory-enhancing effects of these hormones
(Figure 1). Neuromodulators such as noradrenaline and corticos-
teroidswork inoverlapping time-domains andmost likely interact.
Interactions between other stress mediators, though, have not yet
been studied in great detail. There might be some redundancy in
the activity of these stress mediators, but the regional distribution
and sub-cellular localization of their receptors will confer quite
some speciﬁcity to their contribution to the overall stress–response
(Joëls and Baram, 2009).
In the rapid time-domain (i.e., within 30–60 min after stress,
when both hormones are present in high levels in the vicinity of
neurons in limbic areas) noradrenaline and corticosterone seem to
act synergistically; current evidence supports that noradrenaline
is indispensable in the rapid time-domain, whereas corticosterone
seems to serve a more permissive role (Roozendaal et al., 2006).
MRs are important in this phase, among other things for appraisal
of the situation and selection of behavioral strategies (Schwabe
et al., 2010). The behavioral consequences of corticosteroids in
this time-domain however, particularly in humans, still need to
be addressed in detail. Such investigations in human subjects are
presently hampered by the fact that (1) there are no (oral) selective
ligands available for membrane MRs mediating rapid effects and
(2) peripherally administered drugs require some time to reach
the brain, which hampers precise timing such as is possible in
vitro or with intracerebroventricular administration in rodents.
But even in reduced rodent brain preparations, the“natural”order
of hormone exposure – i.e., ﬁrst to noradrenaline and then, with
an approximate delay of 20 min, to corticosteroids – has not been
examined. This clearly requires dedicated experiments, aligning
the experimental designs in the reduced cell preparations, animal
behavior and human studies as much as possible.
The cellular studies in rodents and neuroimaging studies in
humans regarding delayed effects of corticosteroid hormones on
noradrenaline seem tobe quite consistent, all ﬁnding a suppression
of the latter by the former, probably via GRs. The evidence for this
view in the human brain, however, is still limited. More impor-
tantly, support for this notion from behavioral studies in rodents
is near-absent. Dedicated experiments, in which administration
of corticosterone is precisely timed relative to mildly arousing
learning situations, could resolve this issue. To what extent these
experiments with corticosteroid treatment are indicative of what
happens several hours after their release during stress also remains
to be investigated. If this would be the case, one could postu-
late that the delayed effects of corticosteroid hormones primarily
play a role in response normalization after stress and consoli-
dation of the stress-related information, a notion that is indeed
supported by behavioral investigations in humans and experimen-
tal animals. Whether the interactive effects of noradrenaline and
corticosteroids on excitatory synapses are crucial for the memory-
enhancing effects of these neuromodulators needs to be veriﬁed.
A ﬁnal consideration regards the effect of multiple surges of
corticosteroid hormones. Recent cellular investigations in the
rodent basolateral nucleus of the amygdala suggest that expo-
sure to a single surge of corticosterone changes cellular properties
such that these cells respond in the complete opposite way to
a second exposure to corticosteroids (Karst et al., 2010); this
“ﬂip” in response depends on protein synthesis and activation
of GRs. The behavioral relevance of these metaplastic responses
needs further investigation, but given the pulsatile release pattern
of corticosteroid hormones throughout the day (Lightman and
Conway-Campbell, 2010), metaplasticity is likely to change the
background excitability of these amygdala cells, even in the absence
of stress. How this affects the responsivity of amygdala versus hip-
pocampal cells to stress over the day is one of the challenging
questions for the next years.
CONCLUSION
Shortly after stress, cells in limbic brain areas are exposed to a
wave of catecholamines including noradrenaline and, slightly later,
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to corticosteroid hormones. These two stress mediators regulate
synapses and memory performance. They interact in multiple
time-domains: (1) up to approximately 1 h after stress via rapid
non-genomic actions, i.e., while levels of stress mediators are high;
and (2) several hours after stress exposure via genomic effects,
i.e., at a time when concentrations of noradrenaline and cor-
ticosteroids have returned to pre-stress levels. Cellular studies
over the past decade have shown that the two stress mediators
act synergistically in the initial time-window, particularly with
intermediate concentrations. Animal behavior and human stud-
ies indicate that these rapid actions may promote the encoding of
stress-context related and relevant information. The latter actions,
primarily exerted by corticosteroid hormones, may serve to nor-
malize earlier effects of catecholamines and protect the encoded
stress-related information. Corticosteroid hormones given out of
the stress context (e.g., 1–4 h in advance of stress) generally sup-
press noradrenergic facilitation of neuronal activity, as shown in
rodents at the cellular level and in the human brain. In the rodent
amygdala, corticosterone administration after stress quickly resets
neuronal activity. These out-of-context effects of corticosterone
could be of relevance for pharmacotreatment of stress-related
disorders.
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